Kinetic Concepts, Inc. Completes Initial Tender Offer for Shares ofLifeCell Corporation

Kinetic Concepts, Inc. (NYSE: KCI) announced today that it has completed

its initial tender offer for the outstanding shares of common stock of

LifeCell Corporation (NASDAQ: LIFC). More than 91% of the outstanding

shares of common stock of LifeCell have been tendered, making LifeCell a

majority owned subsidiary of KCI. The initial offering period for the tender offer expired at 12:00

midnight, New York City time, on Friday, May 16, 2008, with a total of

approximately 31.25 million LifeCell shares being validly tendered in

the offer and not withdrawn (including approximately 6.2 million shares

delivered through notices of guaranteed delivery), representing

approximately 91.3% of the outstanding shares of common stock of

LifeCell. Shares tendered through notices of guaranteed delivery are

required to be delivered to KCI by Wednesday, May 21, 2008. KCI, through

its wholly–owned subsidiary Leopard Acquisition Sub, Inc. ("Purchaser")

has accepted for purchase all shares that were validly tendered and not

withdrawn during the offer. Subsequent offering period and merger KCI and Purchaser also announced that Purchaser has commenced a

subsequent offering period which will expire at 5:00 p.m., New York City

time, on Friday, May 23, 2008, unless extended. During this subsequent

offering period, holders of shares of LifeCell common stock who did not

previously tender their shares into the offer may do so and KCI and

Purchaser will promptly purchase any shares so tendered at $51.00 per

share, net to the seller in cash. No shares tendered in the tender offer

may be withdrawn during the subsequent offering period. After the expiration of the subsequent offering period KCI intends to

acquire all of the remaining shares of LifeCell common stock by means of

a merger. In the merger, each outstanding LifeCell share not tendered

and purchased in the offer, if any (other than those as to which holders

properly exercise appraisal rights, if any) will be converted into the

right to receive the same $51.00 per share price, without interest and

less any required withholding taxes, that was paid in the tender offer.

As a result of the merger, LifeCell will become a wholly–owned

subsidiary of KCI. Following the merger, LifeCell´s

common stock will cease to be traded on the NASDAQ Global Market. If KCI, through Purchaser, owns at least 90% of the outstanding shares

of LifeCell common stock after the subsequent offering period, the

merger will be implemented on an expedited basis without a vote or

meeting of LifeCell stockholders pursuant to the short–form merger

procedure available under Delaware law. About Kinetic Concepts, Inc. KCI is a global medical technology company with leadership positions in

advanced wound care and therapeutic support systems. We design

manufacture, market and service a wide range of proprietary products

that can improve clinical outcomes and can help reduce the overall cost

of patient care. Our advanced wound care systems incorporate our

proprietary Vacuum Assisted Closure(R), or V.A.C.(R) Therapy technology

which has been demonstrated clinically to promote wound healing through

unique mechanisms of action and can help reduce the cost of treating

patients with serious wounds. Our therapeutic support systems, including

specialty hospital beds, mattress replacement systems and overlays, are

designed to address pulmonary complications associated with immobility

to reduce skin breakdown and assist caregivers in the safe and dignified

handling of obese patients. We have an infrastructure designed to meet

the specific needs of medical professionals and patients across all

healthcare settings, including acute care hospitals, extended care

organizations and patients´ homes, in 19 countries in the United States

and abroad. For more information, visit our web site at www.kci1.com. Securities Law Disclosure This press release is neither an offer to purchase nor a solicitation of

an offer to sell securities. The tender offer is being made pursuant to

a tender offer statement and related materials. LifeCell´s

stockholders are advised to read the tender offer statement and related

materials, as filed by Kinetic Concepts, Inc. with the U.S. Securities

and Exchange Commission (the "SEC").

The tender offer statement (including the Offer to Purchase, letter of

transmittal and related tender offer documents) filed by Kinetic

Concepts, Inc. with the SEC and the solicitation/ recommendation

statement with respect to the offer on Schedule 14D–9 filed by LifeCell

with the SEC contain important information which should be read

carefully before any decision is made with respect to the tender offer. Forward Looking Information This communication contains forward–looking statements, which may be

identified by words such as "believes," "expects," "anticipates,"

"estimates," "projects," "intends," "should," "seeks," "future,"

"continue," or the negative of such terms, or other comparable

terminology. Forward–looking statements are subject to risks

uncertainties, assumptions and other factors that are difficult to

predict and that could cause actual results to vary materially from

those expressed in or indicated by them. Such forward–looking statements

include, but are not limited to, statements about KCI´s ability to

implement its strategic and business initiatives, including its proposed

acquisition of LifeCell Corporation, financial expectations and

intentions and other statements that are not historical facts.

Additional risks and factors are identified in KCI´s filings with the

U.S. Securities Exchange Commission (the "SEC"), including its Annual

Report on Form 10–K for the fiscal year ending December 31, 2007 and

Quarterly Report on Form 10–Q for the quarter ended March 31, 2008

which are available on the SEC´s website at http://www.sec.gov.

KCI undertakes no obligation to revise or update any forward–looking

statement, or to make any other forward–looking statements, whether as a

result of new information, future events or otherwise.